-
公开(公告)号:AU652840B2
公开(公告)日:1994-09-08
申请号:AU1900192
申请日:1992-06-09
Applicant: JANSSEN PHARMACEUTICA NV
IPC: A61K31/55 , A61K33/06 , A61P37/08 , C07D235/00 , C07D487/04 , C07D519/00
Abstract: The present invention is concerned with novel imidazo[2,1-b][3]benzazepines of formula the pharmaceutically acceptable addition salts and stereochemically isomeric forms thereof, wherein each of the dotted lines independently represents an optional bond; R represents hydrogen, halo, C1-4alkyl or C1-4alkyloxy; R represents hydrogen, halo, C1-4alkyl or C1-4alkyloxy; R represents hydrogen, C1-4alkyl, ethenyl substituted with hydroxycarbonyl or C1-4alkyloxycarbonyl, C1-4alkyl substituted with hydroxycarbonyl or C1-4alkyloxycarbonyl, hydroxyC1-4alkyl, formyl or hydroxycarbonyl; R represents hydrogen, C1-4alkyl, hydroxyC1-4alkyl, phenyl or halo; R represents hydrogen, C1-4alkyl or halo; L represents hydrogen; C1-6alkyl; C1-6alkyl substituted with one substituent selected from the group consisting of hydroxy, halo, C1-4alkyloxy, hydroxycarbonyl, C1-4alkyloxycarbonyl, C1-4alkyloxycarbonyl-C1-4alkyloxy, hydroxycarbonylC1-4alkyloxy, C1-4alkyloxycarbonylamino, C1-4alkylaminocarbonyl, C1-4alkylaminocarbonylamino, C1-4alkylaminothiocarbonylamino, aryl, aryloxy and arylcarbonyl; C1-6alkyl substituted with both hydroxy and aryloxy; C3-6alkenyl; C3-6alkenyl substituted with aryl; or, L represents a radical of formula -Alk-Y-Het (a-1), -Alk-NH-CO-Het (a-2) or -Alk-Het (a-3); provided that 6,11-dihydro-11-(4-piperidinylidene)-5H-imidazo[2,1-b][3]benzazepine is ecxluded, which are useful antiallergic compounds. Compositions comprising said compounds, methods of using and processes for preparing the same.
-
公开(公告)号:HRP920155A2
公开(公告)日:1994-08-31
申请号:HRP920155
申请日:1992-06-10
Applicant: JANSSEN PHARMACEUTICA NV
IPC: A61K33/06 , A61K31/55 , A61P37/08 , C07D235/00 , C07D487/04 , C07D519/00 , C07D487/12
Abstract: The present invention is concerned with novel imidazo[2,1-b][3]benzazepines of formula the pharmaceutically acceptable addition salts and stereochemically isomeric forms thereof, wherein each of the dotted lines independently represents an optional bond; R represents hydrogen, halo, C1-4alkyl or C1-4alkyloxy; R represents hydrogen, halo, C1-4alkyl or C1-4alkyloxy; R represents hydrogen, C1-4alkyl, ethenyl substituted with hydroxycarbonyl or C1-4alkyloxycarbonyl, C1-4alkyl substituted with hydroxycarbonyl or C1-4alkyloxycarbonyl, hydroxyC1-4alkyl, formyl or hydroxycarbonyl; R represents hydrogen, C1-4alkyl, hydroxyC1-4alkyl, phenyl or halo; R represents hydrogen, C1-4alkyl or halo; L represents hydrogen; C1-6alkyl; C1-6alkyl substituted with one substituent selected from the group consisting of hydroxy, halo, C1-4alkyloxy, hydroxycarbonyl, C1-4alkyloxycarbonyl, C1-4alkyloxycarbonyl-C1-4alkyloxy, hydroxycarbonylC1-4alkyloxy, C1-4alkyloxycarbonylamino, C1-4alkylaminocarbonyl, C1-4alkylaminocarbonylamino, C1-4alkylaminothiocarbonylamino, aryl, aryloxy and arylcarbonyl; C1-6alkyl substituted with both hydroxy and aryloxy; C3-6alkenyl; C3-6alkenyl substituted with aryl; or, L represents a radical of formula -Alk-Y-Het (a-1), -Alk-NH-CO-Het (a-2) or -Alk-Het (a-3); provided that 6,11-dihydro-11-(4-piperidinylidene)-5H-imidazo[2,1-b][3]benzazepine is ecxluded, which are useful antiallergic compounds. Compositions comprising said compounds, methods of using and processes for preparing the same.
-
公开(公告)号:HU9303553D0
公开(公告)日:1994-04-28
申请号:HU9303553
申请日:1992-06-09
Applicant: JANSSEN PHARMACEUTICA NV
IPC: A61K31/55 , A61K33/06 , A61P37/08 , C07D235/00 , C07D487/04 , C07D519/00
Abstract: The present invention is concerned with novel imidazo[2,1-b][3]benzazepines of formula the pharmaceutically acceptable addition salts and stereochemically isomeric forms thereof, wherein each of the dotted lines independently represents an optional bond; R represents hydrogen, halo, C1-4alkyl or C1-4alkyloxy; R represents hydrogen, halo, C1-4alkyl or C1-4alkyloxy; R represents hydrogen, C1-4alkyl, ethenyl substituted with hydroxycarbonyl or C1-4alkyloxycarbonyl, C1-4alkyl substituted with hydroxycarbonyl or C1-4alkyloxycarbonyl, hydroxyC1-4alkyl, formyl or hydroxycarbonyl; R represents hydrogen, C1-4alkyl, hydroxyC1-4alkyl, phenyl or halo; R represents hydrogen, C1-4alkyl or halo; L represents hydrogen; C1-6alkyl; C1-6alkyl substituted with one substituent selected from the group consisting of hydroxy, halo, C1-4alkyloxy, hydroxycarbonyl, C1-4alkyloxycarbonyl, C1-4alkyloxycarbonyl-C1-4alkyloxy, hydroxycarbonylC1-4alkyloxy, C1-4alkyloxycarbonylamino, C1-4alkylaminocarbonyl, C1-4alkylaminocarbonylamino, C1-4alkylaminothiocarbonylamino, aryl, aryloxy and arylcarbonyl; C1-6alkyl substituted with both hydroxy and aryloxy; C3-6alkenyl; C3-6alkenyl substituted with aryl; or, L represents a radical of formula -Alk-Y-Het (a-1), -Alk-NH-CO-Het (a-2) or -Alk-Het (a-3); provided that 6,11-dihydro-11-(4-piperidinylidene)-5H-imidazo[2,1-b][3]benzazepine is ecxluded, which are useful antiallergic compounds. Compositions comprising said compounds, methods of using and processes for preparing the same.
-
公开(公告)号:NO934493A
公开(公告)日:1994-01-04
申请号:NO934493
申请日:1993-12-09
Applicant: JANSSEN PHARMACEUTICA NV
Inventor: JANSSENS FRANS EDUARD , DIELS GASTON STANISLAS MARCELL , LEENAERTS JOSEPH ELISABETH , COOYMANS LUDWIG PAUL
IPC: A61K31/55 , A61P37/08 , C07D235/00 , C07D487/14 , C07D491/14 , C07D491/147 , C07D495/14 , C07D519/00 , C07D
CPC classification number: C07D487/14 , C07D491/14 , C07D495/14
-
95.
公开(公告)号:ZA924327B
公开(公告)日:1993-12-13
申请号:ZA924327
申请日:1992-06-12
Applicant: JANSSEN PHARMACEUTICA NV
Inventor: JANSSENS FRANS EDUARD , DIELS GASTON STANISLAS MARCELL , LEENAERTS JOSEPH ELISABETH , COOYMANS LUDWIG PAUL
IPC: A61K31/55 , A61P37/08 , C07D235/00 , C07D487/14 , C07D491/14 , C07D491/147 , C07D495/14 , C07D519/00 , C07D , A61K , C07B
Abstract: The present invention is concerned with novel imidazo[1,2-a](pyrrolo, thieno or furano)[3,2-d]azepines of formula the pharmaceutically acceptable addition salts and stereochemically isomeric forms thereof, wherein each of the dotted lines independently represents an optional bond; R represents hydrogen, C1-4alkyl, halo, ethenyl substituted with hydroxycarbanyl or C1-4alkyloxycarbonyl, hydroxyC1-4alkyl, formyl, hydroxycarbonyl or hydroxycarbonylC1-4alkyl; R represents hydrogen, C1-4alkyl, ethenyl substituted with hydroxycarbonyl or C1-4alkyloxycarbonyl, C1-4alkyl substituted with hydroxycarbonyl or C1-4alkyloxycarbonyl, hydroxyC1-4alkyl, formyl or hydroxycarbonyl; R represents hydrogen, C1-4alkyl, hydroxyC1-4alkyl, phenyl or halo; L represents hydrogen; C1-6alkyl; C1-6alkyl substituted with one substituent selected from the group consisting of hydroxy, halo, C1-4alkyloxy, hydroxycarbonyl, C1-4alkyloxycarbonyl, C1-4alkyloxycarbonylC1-4alkyloxy, hydroxycarbonylC1-4alkyloxy, C1-4alkyloxycarbonylamino, C1-4alkylaminocarbonyl, C1-4alkylaminocarbonylamino, C1-4alkylaminothiocarbonylamino, aryl, aryloxy and arylcarbonyl; C1-6alkyl substituted with both hydroxy and aryloxy; C3-6alkenyl; C3-6alkenyl substituted with aryl; L represents a radical of formula -Alk-Y-Het (a-1), -Alk-NH-CO-Het (a-2) or -Alk-Het (a-3); which are useful antiallergic compounds. Compositions comprising said compounds, methods of using, and processes for preparing the same.
-
公开(公告)号:ZA924326B
公开(公告)日:1993-12-13
申请号:ZA924326
申请日:1992-06-12
Applicant: JANSSEN PHARMACEUTICA NV
IPC: A61K20060101 , C07B20060101 , C07D20060101 , C07D487/04 , C07D513/04 , C07D , A61K , C07B
-
公开(公告)号:FI935557A0
公开(公告)日:1993-12-10
申请号:FI935557
申请日:1993-12-10
Applicant: JANSSEN PHARMACEUTICA NV
Inventor: JANSSENS FRANS EDUARD , DIELS GASTON STANISLAS MARCELL , LEENAERTS JOSEPH ELISABETH , COOYMANS LUDWIG PAUL
IPC: A61K31/55 , A61P37/08 , C07D235/00 , C07D487/14 , C07D491/14 , C07D491/147 , C07D495/14 , C07D519/00 , C07D
Abstract: The present invention is concerned with novel imidazo[1,2-a](pyrrolo, thieno or furano)[3,2-d]azepines of formula the pharmaceutically acceptable addition salts and stereochemically isomeric forms thereof, wherein each of the dotted lines independently represents an optional bond; R represents hydrogen, C1-4alkyl, halo, ethenyl substituted with hydroxycarbanyl or C1-4alkyloxycarbonyl, hydroxyC1-4alkyl, formyl, hydroxycarbonyl or hydroxycarbonylC1-4alkyl; R represents hydrogen, C1-4alkyl, ethenyl substituted with hydroxycarbonyl or C1-4alkyloxycarbonyl, C1-4alkyl substituted with hydroxycarbonyl or C1-4alkyloxycarbonyl, hydroxyC1-4alkyl, formyl or hydroxycarbonyl; R represents hydrogen, C1-4alkyl, hydroxyC1-4alkyl, phenyl or halo; L represents hydrogen; C1-6alkyl; C1-6alkyl substituted with one substituent selected from the group consisting of hydroxy, halo, C1-4alkyloxy, hydroxycarbonyl, C1-4alkyloxycarbonyl, C1-4alkyloxycarbonylC1-4alkyloxy, hydroxycarbonylC1-4alkyloxy, C1-4alkyloxycarbonylamino, C1-4alkylaminocarbonyl, C1-4alkylaminocarbonylamino, C1-4alkylaminothiocarbonylamino, aryl, aryloxy and arylcarbonyl; C1-6alkyl substituted with both hydroxy and aryloxy; C3-6alkenyl; C3-6alkenyl substituted with aryl; L represents a radical of formula -Alk-Y-Het (a-1), -Alk-NH-CO-Het (a-2) or -Alk-Het (a-3); which are useful antiallergic compounds. Compositions comprising said compounds, methods of using, and processes for preparing the same.
-
公开(公告)号:ZA902664B
公开(公告)日:1991-12-24
申请号:ZA902664
申请日:1990-04-05
Applicant: JANSSEN PHARMACEUTICA NV
Inventor: JANSSENS FRANS EDUARD , FRANS EDUARD JANSSENS , DIELS GASTON STANISLAS MARCELL , GASTON STANISLAS MARCELLA DIEL , LEENAERTS JOSEPH ELISABETH , JOSEPH ELISABETH LEENAERTS
IPC: A61K31/341 , A61K31/415 , A61K31/4184 , A61K31/4409 , A61K31/443 , A61K31/445 , A61K31/4523 , A61K31/495 , A61K31/55 , A61P37/08 , A61P43/00 , C07D405/12 , C07D405/14 , C07D413/14 , C07D471/04 , C07D473/00 , C07D498/04 , C07D513/04 , C07D519/00 , A61K , C07D
Abstract: Hydroxylalkylfuranyl derivatives of formula wherein -A =A -A =A - is -CH=CH-CH=CH-, -N=CH-CH=CH-, -CH=N-CH=CH-, -CH=CH-N=CH-, -CH=CH-CH=N-, -N=CH-N=CH- or -CH=N-CH=N- ; D is C1-4alkanediyl ; R is hydrogen, C1-6alkyl, arylC1-6alkyl or C1-6alkylcarbonyl ; R and R are hydrogen or C1-6alkyl ; n is 0, 1 or 2 ; B is NR , O, S, SO2 or CH2; R is hydrogen, C1-6alkyl, C3-6cycloalkyl or arylC1-6alkyl ; L is hydrogen, C1-12alkyl, C3-6cycloalkyl, C3-6alkenyl optionally substituted with aryl, C1-6alkylcarbonyl, C1-6alkyloxycarbonyl, arylcarbonyl, arylC1-6alkyloxycarbonyl, C1-6alkylsulfonyl, arylsulfonyl, or a radical of formula -Alk-R , -Alk-Y-R , -Alk-Z -C(=X)-Z -R , or -CH2-CHOH-CH2-O-R , the acid addition salts and stereochemically isomeric forms thereof, said compounds having antiallergic activity. Pharmaceutical compositions containing such compounds as an active ingredient; methods of preparing said compounds and pharmaceutical compositions.
-
公开(公告)号:NZ233088A
公开(公告)日:1991-10-25
申请号:NZ23308890
申请日:1990-03-26
Applicant: JANSSEN PHARMACEUTICA NV
IPC: A61K31/341 , A61K31/415 , A61K31/4184 , A61K31/4409 , A61K31/443 , A61K31/445 , A61K31/4523 , A61K31/495 , A61K31/55 , A61P37/08 , A61P43/00 , C07D405/12 , C07D405/14 , C07D413/14 , C07D471/04 , C07D473/00 , C07D498/04 , C07D513/04 , C07D519/00 , C07D409/14 , C07D473/34 , A61K31/34 , A61K31/52 , A61K31/54 , A61K31/505
Abstract: Hydroxylalkylfuranyl derivatives of formula wherein -A =A -A =A - is -CH=CH-CH=CH-, -N=CH-CH=CH-, -CH=N-CH=CH-, -CH=CH-N=CH-, -CH=CH-CH=N-, -N=CH-N=CH- or -CH=N-CH=N- ; D is C1-4alkanediyl ; R is hydrogen, C1-6alkyl, arylC1-6alkyl or C1-6alkylcarbonyl ; R and R are hydrogen or C1-6alkyl ; n is 0, 1 or 2 ; B is NR , O, S, SO2 or CH2; R is hydrogen, C1-6alkyl, C3-6cycloalkyl or arylC1-6alkyl ; L is hydrogen, C1-12alkyl, C3-6cycloalkyl, C3-6alkenyl optionally substituted with aryl, C1-6alkylcarbonyl, C1-6alkyloxycarbonyl, arylcarbonyl, arylC1-6alkyloxycarbonyl, C1-6alkylsulfonyl, arylsulfonyl, or a radical of formula -Alk-R , -Alk-Y-R , -Alk-Z -C(=X)-Z -R , or -CH2-CHOH-CH2-O-R , the acid addition salts and stereochemically isomeric forms thereof, said compounds having antiallergic activity. Pharmaceutical compositions containing such compounds as an active ingredient; methods of preparing said compounds and pharmaceutical compositions.
-
公开(公告)号:HU902107D0
公开(公告)日:1990-07-28
申请号:HU210790
申请日:1990-04-06
Applicant: JANSSEN PHARMACEUTICA NV
IPC: A61K31/341 , A61K31/415 , A61K31/4184 , A61K31/4409 , A61K31/443 , A61K31/445 , A61K31/4523 , A61K31/495 , A61K31/55 , A61P37/08 , A61P43/00 , C07D405/12 , C07D405/14 , C07D413/14 , C07D471/04 , C07D473/00 , C07D498/04 , C07D513/04 , C07D519/00
Abstract: Hydroxylalkylfuranyl derivatives of formula wherein -A =A -A =A - is -CH=CH-CH=CH-, -N=CH-CH=CH-, -CH=N-CH=CH-, -CH=CH-N=CH-, -CH=CH-CH=N-, -N=CH-N=CH- or -CH=N-CH=N- ; D is C1-4alkanediyl ; R is hydrogen, C1-6alkyl, arylC1-6alkyl or C1-6alkylcarbonyl ; R and R are hydrogen or C1-6alkyl ; n is 0, 1 or 2 ; B is NR , O, S, SO2 or CH2; R is hydrogen, C1-6alkyl, C3-6cycloalkyl or arylC1-6alkyl ; L is hydrogen, C1-12alkyl, C3-6cycloalkyl, C3-6alkenyl optionally substituted with aryl, C1-6alkylcarbonyl, C1-6alkyloxycarbonyl, arylcarbonyl, arylC1-6alkyloxycarbonyl, C1-6alkylsulfonyl, arylsulfonyl, or a radical of formula -Alk-R , -Alk-Y-R , -Alk-Z -C(=X)-Z -R , or -CH2-CHOH-CH2-O-R , the acid addition salts and stereochemically isomeric forms thereof, said compounds having antiallergic activity. Pharmaceutical compositions containing such compounds as an active ingredient; methods of preparing said compounds and pharmaceutical compositions.
-
-
-
-
-
-
-
-
-